The agreement grants Lupin the right to introduce Vonoprazan, an innovative treatment for Acid Peptic Disorders (APD), which include Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD)
Read More
The partnership aims to attract medical tourists primarily for treatments in cardiology, cardiothoracic surgery, neurology, gastroenterology, and orthopedics
Read More
